John Kerr (pathologist)

Last updated

John Foxton Ross Kerr
AO
Born(1934-01-24)24 January 1934
Sydney, Australia
Died4 June 2024(2024-06-04) (aged 90)
NationalityAustralian
Alma mater
Known for
Scientific career
Fields Pathology
Institutions

John Foxton Ross Kerr AO (24 January 1934 – 4 June 2024) [1] was an Australian pathologist. He was the first to describe the ultrastructural changes in apoptosis, and could show that they differ significantly from the changes that occur in necrosis, another form of cell death. For the first time, he placed the roles of cell death in normal adult mammals, and in disease, into scientific focus. [2]

Contents

Biography

Education

Kerr studied at the University of Queensland in Brisbane, Australia. In 1955, Kerr earned a Bachelor of Science (BSc) degree, and in 1957, a Bachelor of Medicine, Bachelor of Surgery (MBBS). As a medical assistant, he worked at the Royal Brisbane Hospital. In 1964, he earned a PhD at the University of London.[ citation needed ]

Academic career

Starting in 1965, he taught pathology at the University of Queensland, and was made a professor in 1974. He became a professor emeritus in 1995. [2]

Kerr, in collaboration with Andrew Wyllie and Alastair Currie, coined the term apoptosis to describe natural developmental cell death. [3]

Awards and honours

Kerr has received numerous awards and honours:

Notes and references

Bibliography
Notes
  1. "Fellows update: June 2024". Australian Academy of Science. Retrieved 3 July 2024.
  2. 1 2 "Kerr, John Foxton Ross (1934 - )". Encyclopedia of Australian Science. 14 February 2006. Retrieved 15 July 2015.
  3. Kerr, J. F. R.; Wyllie, A. H.; Currie, A. R. (1972). "Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics". British Journal of Cancer. 26 (4): 239–257. doi: 10.1038/bjc.1972.33 . PMC   2008650 . PMID   4561027.
  4. "Award Extract - Dr John Foxton Ross Kerr". Australian Honours Search Facility. Canberra, Australia: Department of the Prime Minister and Cabinet . Retrieved 15 May 2011.
  5. "Professor John Kerr". Australian Academy of Science. Archived from the original on December 8, 2015. Retrieved July 15, 2015.
  6. "Preisträger des Paul Ehrlich und Ludwig Darmstaedter-Preises" [Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize]. Goethe University Frankfurt (in German). Archived from the original on 2 March 2012. Retrieved 15 May 2011.
  7. "Charles IV Prize". Charles IV Prize. Retrieved 15 May 2011.

Related Research Articles

<span class="mw-page-title-main">Bonnie Bassler</span> American molecular biologist

Bonnie Lynn Bassler is an American molecular biologist; the Squibb Professor in Molecular Biology and chair of the Department of Molecular Biology at Princeton University; and a Howard Hughes Medical Institute Investigator. She has researched cell-to-cell chemical communication in bacteria and discovered key insights into the mechanism by which bacteria communicate, known as quorum sensing. She has contributed to the idea that disruption of chemical signaling can be used as an antimicrobial therapy.

<span class="mw-page-title-main">H. Robert Horvitz</span> American biologist

Howard Robert Horvitz ForMemRS NAS AAA&S APS NAM is an American biologist best known for his research on the nematode worm Caenorhabditis elegans, for which he was awarded the 2002 Nobel Prize in Physiology or Medicine, together with Sydney Brenner and John E. Sulston, whose "seminal discoveries concerning the genetic regulation of organ development and programmed cell death" were "important for medical research and have shed new light on the pathogenesis of many diseases".

Jacques Francis Albert Pierre Miller AC FRS FAA is a French-Australian research scientist. He is known for having discovered the function of the thymus and for the identification of mammalian species of the two major subsets of lymphocytes and their function.

Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.

<span class="mw-page-title-main">Bert Vogelstein</span> American oncologist (born 1949)

Bert Vogelstein is director of the Ludwig Center, Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at The Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center. A pioneer in the field of cancer genomics, his studies on colorectal cancers revealed that they result from the sequential accumulation of mutations in oncogenes and tumor suppressor genes. These studies now form the paradigm for modern cancer research and provided the basis for the notion of the somatic evolution of cancer.

<span class="mw-page-title-main">Pamela Bjorkman</span> American biochemist

Pamela Jane Bjorkman NAS, AAAS is an American biochemist and molecular biologist. She is the David Baltimore Professor of Biology and Biological Engineering at the California Institute of Technology (Caltech). Her research centers on the study of the three-dimensional structures of proteins related to Class I MHC, or Major Histocompatibility Complex, proteins of the immune system, and proteins involved in the immune responses to viruses. Bjorkman's goal is to improve current therapeutic applications. Bjorkman is most well known as a pioneer in the field of structural biology.

Andrew David Hamilton Wyllie FMedSci FRS was a Scottish pathologist. In 1972, while working with electron microscopes at the University of Aberdeen he realised the significance of natural cell death. He and his colleagues John Kerr and Alastair Currie called this process apoptosis, from the use of this word in an ancient Greek poem to mean "falling off". He completed postdoctoral training in Cambridge University and became Professor of Experimental Pathology at the University of Edinburgh Medical School in 1992. He left Edinburgh for a chair at Cambridge in 1998 where he continued to lecture to undergraduate medical and natural sciences students. His works have contributed to the understanding of apoptosis in health and in disease. Apoptosis is used during early development to eliminate unwanted cells; for example, those between the fingers of a developing hand. In adults, apoptosis is used to rid the body of cells that have been damaged beyond repair. Apoptosis also plays a critical role in preventing cancer. If apoptosis is for some reason prevented, it can lead to uncontrolled cell division and the subsequent development of a tumour.

<span class="mw-page-title-main">Kimishige Ishizaka</span> Japanese immunologist (1925–2018)

Kimishige "Kimi" Ishizaka was a Japanese immunologist who, with his wife Teruko Ishizaka, discovered the antibody class Immunoglobulin E (IgE) in 1966–1967. Their work was regarded as a major breakthrough in the understanding of allergy. He was awarded the 1973 Gairdner Foundation International Award and the 2000 Japan Prize for his work in immunology.

Sir John Stewart Savill, FRS, FMedSci is the Chief Executive of the Medical Research Council (MRC) in the UK and the Head of the College of Medicine and Veterinary Medicine and a Vice Principal of the University of Edinburgh.

Franz-Ulrich Hartl is a German biochemist and the current Executive Director of the Max Planck Institute of Biochemistry. He is known for his pioneering work in chaperone-mediated protein folding.

<span class="mw-page-title-main">John Kappler</span>

John Wayne Kappler is a professor in the Department of Integrated Immunology at National Jewish Health. His principal research is in T cell biology, a subject he collaborates on with his wife Philippa Marrack. In 1983 they discovered the T cell receptor, together with Ellis Reinherz and James Allison.

The Paul Ehrlich and Ludwig Darmstaedter Prize is an annual award bestowed by the Paul Ehrlich Foundation since 1952 for investigations in medicine. It carries a prize money of 120,000 Euro. The prize awarding ceremony is traditionally held on 14 March, the birthday of Nobel laureate Paul Ehrlich, in the St. Paul's Church, Frankfurt am Main.

<span class="mw-page-title-main">James Learmonth Gowans</span> British immunologist (1924–2020)

Sir James Learmonth "Jim" Gowans was a British physician and immunologist. In 1945, while studying medicine at King's College Hospital, he assisted at the liberated Bergen-Belsen concentration camp as a voluntary medical student.

Frederick W. Alt is an American geneticist. He is a member of the Immunology section of the National Academy of Sciences and a Charles A. Janeway Professor of Pediatrics, and Professor of Genetics at Harvard Medical School. He is the Director of the Program in Cellular and Molecular Medicine at the Boston Children's Hospital. He is a Howard Hughes Medical Institute investigator, since 1987.

Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

<span class="mw-page-title-main">Cesare Montecucco</span>

Cesare Montecucco is an Italian pathologist and full professor at University of Padua, Italy. He was awarded the Paul Ehrlich and Ludwig Darmstaedter Prize in 2011 for his research on tetanus, botulism, anthrax and Helicobacter pylori-related diseases.

Sir Alastair Robert Currie PRSE FRCPE FRCPGlas FRCP FRCPath LLD was a Scottish pathologist, who was Professor of Pathology, at Edinburgh University, 1972–86, and then emeritus. He was eminent in the field of cancer research and humanitarian causes.

<span class="mw-page-title-main">Shimon Sakaguchi</span>

Shimon Sakaguchi is an immunologist and a Distinguished Professor of Osaka University. He is best known for the discovery of regulatory T cells and to describe their role in the immune system. This discovery is used in the treatment of cancer and autoimmune diseases.

<span class="mw-page-title-main">Andrea Ablasser</span> German immunologist

Andrea Ablasser is a German immunologist, who works as a full professor of Life Sciences at the École Polytechnique Fédérale de Lausanne. Her research has focused on how the innate immune system is able to recognise virus-infected cells and pathogens.

<span class="mw-page-title-main">George Mackaness</span> Australian immunologist (1922–2007)

George Bellamy Mackaness was an Australian professor of microbiology, immunologist, writer and administrator, who researched and described the life history of the macrophage. He showed that by infecting mice with intracellular bacteria, macrophages could be activated to attack other bacteria, triggering further research on "macrophage activation", a term he has come to be associated with.